Plexāā’s BLOOM⁴³ Prehab™ & Preconditioning Platform for Breast Surgery Launches in the U.S.
LOS ANGELES — Oct. 1, 2025 – Plexāā, a medtech company focused on improving surgical outcomes through devices and digital products, announced today on the first day of Breast Cancer Awareness Month the U.S. launch of its BLOOM⁴³ platform — a unique combination of a wearable preconditioning medical device and app developed to prepare patients for breast surgery. The BLOOM⁴³ device, worn at home prior to surgery, uses a technique called Supraphysiological Preconditioning™ to boost skin resilience. Clinical trials have shown that this technique can support wound healing and help prevent post-operative complications associated with breast procedures.